nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Advances in antibody phage display technology
|
Ledsgaard, Line |
|
|
27 |
8 |
p. 2151-2169 |
artikel |
2 |
Advancing automation in high-throughput screening: Modular unguarded systems enable adaptable drug discovery
|
Hansel, Catherine S. |
|
|
27 |
8 |
p. 2051-2056 |
artikel |
3 |
An insight into gastrointestinal macromolecule delivery using physical oral devices
|
Kaffash, Ehsan |
|
|
27 |
8 |
p. 2309-2321 |
artikel |
4 |
APJ/apelin: A promising target for the treatment of retinopathy of prematurity
|
Su, Jingtian |
|
|
27 |
8 |
p. 2342-2352 |
artikel |
5 |
Approaches to advance drug discovery for neglected tropical diseases
|
Ferreira, Leonardo L.G. |
|
|
27 |
8 |
p. 2278-2287 |
artikel |
6 |
Back on the scene: Advances and challenges in CD3-related drugs in tumor therapy
|
Deng, Han |
|
|
27 |
8 |
p. 2199-2208 |
artikel |
7 |
Bacterial cancer therapy: A turning point for new paradigms
|
Mayakrishnan, Vijayakumar |
|
|
27 |
8 |
p. 2043-2050 |
artikel |
8 |
Collaborative university–industry R&D practices supporting the pharmaceutical innovation process: Insights from a bibliometric review
|
Ma, Zhongxuan |
|
|
27 |
8 |
p. 2333-2341 |
artikel |
9 |
Computational elucidation of allosteric communication in proteins for allosteric drug design
|
Ni, Duan |
|
|
27 |
8 |
p. 2226-2234 |
artikel |
10 |
Contents page
|
|
|
|
27 |
8 |
p. i-iii |
artikel |
11 |
Data considerations for predictive modeling applied to the discovery of bioactive natural products
|
Xue, Hai Tao |
|
|
27 |
8 |
p. 2235-2243 |
artikel |
12 |
Emerging role of oncolytic viruses and stem cells in gene therapy: Should they be integrated?
|
Tahir, Muhammad |
|
|
27 |
8 |
p. 2244-2251 |
artikel |
13 |
Engineered nasal dry powder for the encapsulation of bioactive compounds
|
Baldelli, Alberto |
|
|
27 |
8 |
p. 2300-2308 |
artikel |
14 |
Four scenarios for the future of medicines and social policy in 2030
|
Leufkens, Hubert G. |
|
|
27 |
8 |
p. 2252-2260 |
artikel |
15 |
From traditional to data-driven medicinal chemistry: A case study
|
Kunimoto, Ryo |
|
|
27 |
8 |
p. 2065-2070 |
artikel |
16 |
Impact of fenofibrate on NAFLD/NASH: A genetic perspective
|
Mahmoudi, Ali |
|
|
27 |
8 |
p. 2363-2372 |
artikel |
17 |
2021 in review: FDA approvals of new medicines
|
Kinch, Michael S. |
|
|
27 |
8 |
p. 2057-2064 |
artikel |
18 |
Key regulatory miRNAs in lipid homeostasis: Implications for cardiometabolic diseases and development of novel therapeutics
|
Khan, Abrar A. |
|
|
27 |
8 |
p. 2170-2180 |
artikel |
19 |
Long noncoding RNAs (lncRNAs) in pancreatic cancer progression
|
Ashrafizadeh, Milad |
|
|
27 |
8 |
p. 2181-2198 |
artikel |
20 |
Machine Learning guided early drug discovery of small molecules
|
Pillai, Nikhil |
|
|
27 |
8 |
p. 2209-2215 |
artikel |
21 |
Multimodal molecular imaging in drug discovery and development
|
Vermeulen, Isabeau |
|
|
27 |
8 |
p. 2086-2099 |
artikel |
22 |
Novel and investigational therapies for wet and dry age-related macular degeneration
|
Sarkar, Aira |
|
|
27 |
8 |
p. 2322-2332 |
artikel |
23 |
Opportunities and challenges of physiologically based pharmacokinetic modeling in drug delivery
|
Wang, Wei |
|
|
27 |
8 |
p. 2100-2120 |
artikel |
24 |
Overlapping biosimilar and originator follitropin alfa preparations: How much closer can they get?
|
de Mora, Fernando |
|
|
27 |
8 |
p. 2071-2075 |
artikel |
25 |
Pharmaceutical strategies for the treatment of bacterial biofilms in chronic wounds
|
Razdan, Karan |
|
|
27 |
8 |
p. 2137-2150 |
artikel |
26 |
PIMT/TGS1: An evolving metabolic molecular switch with conserved methyl transferase activity
|
Edwin, Rebecca Kristina |
|
|
27 |
8 |
p. 2386-2393 |
artikel |
27 |
Recent advances in dual-ligand targeted nanocarriers for cancer therapy
|
Khan, Nabab |
|
|
27 |
8 |
p. 2288-2299 |
artikel |
28 |
Selection of data sets for FAIRification in drug discovery and development: Which, why, and how?
|
Alharbi, Ebtisam |
|
|
27 |
8 |
p. 2080-2085 |
artikel |
29 |
Selenium as an emerging versatile player in heterocycles and natural products modification
|
Hou, Wei |
|
|
27 |
8 |
p. 2268-2277 |
artikel |
30 |
Surface-enhanced Raman scattering biosensors for detection of oncomiRs in breast cancer
|
Chauhan, Prachi |
|
|
27 |
8 |
p. 2121-2136 |
artikel |
31 |
Targeting autophagy in colorectal cancer: An update on pharmacological small-molecule compounds
|
Li, Zixiang |
|
|
27 |
8 |
p. 2373-2385 |
artikel |
32 |
Thermott: A comprehensive online tool for protein–ligand binding constant determination
|
Gedgaudas, Marius |
|
|
27 |
8 |
p. 2076-2079 |
artikel |
33 |
The role of irisin in metabolic flexibility: Beyond adipose tissue browning
|
Shen, Shengnan |
|
|
27 |
8 |
p. 2261-2267 |
artikel |
34 |
Web support for the more efficient discovery of kinase inhibitors
|
Chen, Yi |
|
|
27 |
8 |
p. 2216-2225 |
artikel |
35 |
Yes SIR! On the structure–inactivity relationships in drug discovery
|
López-López, Edgar |
|
|
27 |
8 |
p. 2353-2362 |
artikel |